Sales of branded drugs dropped by 1.
4% in 2014, while generics grew by 9.
5% Bayer pharmaceuticals invested more compared to four billion eurosin study and development in oncology, ophthalmology, women's health, cardiology and hematology in Asian America.
how to be a pharmaceutical sales rep
According to Laura González-Molero, president of Bayer HealthCare Pharmaceuticals Latin America division, half of which usually is invested in research to be able to pharmaceutical division will be allocated in order to be able to speed time-phases of development, approval and registration of new molecules.
There will be five therapeutic areas within which Bayer will focus its research efforts, these types of oncology, ophthalmology, women's wellness, cardiology and hematology.
In Bayer are determined to continue our commitment in order to innovation and launch new molecules in Latin The united states still meet unmet demands, "stated the president.
Please visit my website: how to be a pharmaceutical rep to get you in the spped track and to finally secure your splendid job.
In addition, González-Molero has highlighted the "successful" "balance sheet" associated with the company in typically the region in fiscal 2014, with 42.
2 billion euros in sales and an increase of 7.
2% over the previous yr.
The market for health professional prescribed drugs (basically consists associated with branded drugs, without or with patent in force) vacation within 2014 fell 1 ) 4% while sales of generic products during this period grew by 9.
5% as recorded Bulletin Medications Market Situation in Spain number 118 which compiles monthly the pharmaceutical industry.
These data show the particular duality in which is immersed, both public and private Spanish pharmaceutical market, along with significant growth in revenue of generic and rough declines in sales of patented medicines.
This circumstance, which marked the basic trend last year, is not necessarily expected very different in 2015, as have forecasted the leading industry analysts.
The Bulletin is also collects the generic industry price represents almost 80 percent of the prescription drug market in Spain (78.
3%), and 47.
Likewise please come and join the facebook web page: how to become a pharmaceutical sales rep and the linkedin page: how to get a job in pharmaceutical sales 9% in the market in investments, experiencing growth very important in recent years.
Only two years ago, within 2012, the marketplace share regarding generic drugs price was 67.
1% in models and 39.
6% inside value, implying an boost of the market discuss of these drugs 17% inside units and 21% found in value in just 2 years.
On the other hand, the Bulletin examines the regional pharmaceutical market last year, showing the particular dispersion of public pharmaceutic expenditure per capita, ranging from 268 euros per person in Extremadura to 163 euros de Baleares, without having regard to the independent cities of Ceuta plus Melilla.
This dispersion provides been reduced in The country of spain last year, since the coefficient of variation provides risen from 13.
2% in 2013 to twelve.
7% in 2014.
Based to available data, 1 of the most essential variables that make the particular pharmaceutical expenditure per capita, as in the situation associated with prescriptions per capita intake, differs both involving the diverse regions is the diverse degree of aging population
